Published in PLoS Negl Trop Dis on June 09, 2009
Helminth infections and host immune regulation. Clin Microbiol Rev (2012) 2.02
Strongyloides stercoralis: there but not seen. Curr Opin Infect Dis (2010) 1.60
Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells. J Immunol (2010) 1.02
Regulatory T cells and parasites. J Biomed Biotechnol (2011) 0.88
Influence of HTLV-1 on the clinical, microbiologic and immunologic presentation of tuberculosis. BMC Infect Dis (2012) 0.88
Relationship Among Strongyloides stercoralis Infection, Human T-Cell Lymphotropic Virus Type 1 Infection, and Cancer: A 24-Year Cohort Inpatient Study in Okinawa, Japan. Am J Trop Med Hyg (2015) 0.88
Foxp3⁺ regulatory T cells delay expulsion of intestinal nematodes by suppression of IL-9-driven mast cell activation in BALB/c but not in C57BL/6 mice. PLoS Pathog (2014) 0.87
Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo. PLoS Pathog (2013) 0.86
Parasite Antigen-Specific Regulation of Th1, Th2, and Th17 Responses in Strongyloides stercoralis Infection. J Immunol (2015) 0.85
Disseminated Strongyloides stercoralis infection in HTLV-1-associated adult T-cell leukemia/lymphoma. Acta Haematol (2011) 0.83
Nematode modulation of inflammatory bowel disease. Protoplasma (2011) 0.83
The two faces of heterologous immunity: protection or immunopathology. J Leukoc Biol (2013) 0.80
Are increased Foxp3+ regulatory T cells responsible for immunosuppression during HTLV-1 infection? Case reports and review of the literature. BMJ Case Rep (2012) 0.79
Dexamethasone effects in the Strongyloides venezuelensis infection in a murine model. Am J Trop Med Hyg (2011) 0.79
Immunization with the recombinant antigen Ss-IR induces protective immunity to infection with Strongyloides stercoralis in mice. Vaccine (2011) 0.78
Systemic Cytokine Profiles in Strongyloides stercoralis Infection and Alterations following Treatment. Infect Immun (2015) 0.78
HTLV-1, Immune Response and Autoimmunity. Viruses (2015) 0.77
IL-10- and TGFβ-mediated Th9 Responses in a Human Helminth Infection. PLoS Negl Trop Dis (2016) 0.77
Effect of different stages of Schistosoma mansoni infection on the parasite burden and immune response to Strongyloides venezuelensis in co-infected mice. Parasitol Res (2015) 0.76
Strongyloidiasis Current Status with Emphasis in Diagnosis and Drug Research. J Parasitol Res (2017) 0.75
Pulmonary strongyloidiasis: assessment between manifestation and radiological findings in 16 severe strongyloidiasis cases. BMC Infect Dis (2017) 0.75
Opportunistic Infections in Patients with HTLV-1 Infection. Case Rep Hematol (2015) 0.75
CD4+ T cell subsets and Tax expression in HTLV-1 associated diseases. Pathog Glob Health (2013) 0.75
Impairment of the humoral and CD4(+) T cell responses in HTLV-1-infected individuals immunized with tetanus toxoid. Hum Immunol (2016) 0.75
Detection of Tax-specific CTLs in lymph nodes of adult T-cell leukemia/lymphoma patients and its association with Foxp3 positivity of regulatory T-cell function. Oncol Lett (2017) 0.75
Peripheral blood CD4(+)/CD25(+) regulatory T cells in alcoholic patients with Strongyloides stercoralis infection. Parasitol Res (2017) 0.75
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature (2002) 11.79
The eosinophil. Annu Rev Immunol (2006) 7.06
CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat Immunol (2007) 6.94
Protective immune mechanisms in helminth infection. Nat Rev Immunol (2007) 5.66
Strongyloides stercoralis in the Immunocompromised Population. Clin Microbiol Rev (2004) 5.41
Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1. EMBO J (1986) 4.58
Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol (2007) 4.56
Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis (2007) 3.80
The role of eosinophils in host defense against helminth parasites. J Allergy Clin Immunol (2004) 2.13
Strongyloides hyperinfection syndrome: an emerging global infectious disease. Trans R Soc Trop Med Hyg (2008) 2.09
Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru. Am J Trop Med Hyg (1999) 1.95
Why does HIV infection not lead to disseminated strongyloidiasis? J Infect Dis (2004) 1.76
Intestinal strongyloidiasis and hyperinfection syndrome. Clin Mol Allergy (2006) 1.71
Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis. Parasite Immunol (2005) 1.64
Role of IL-5 in innate and adaptive immunity to larval Strongyloides stercoralis in mice. J Immunol (2000) 1.61
High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response. Blood (2007) 1.43
Strongyloides stercoralis: eosinophil-dependent immune-mediated killing of third stage larvae in BALB/cByJ mice. Exp Parasitol (1996) 1.27
HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis. Parasite Immunol (2001) 1.25
Eosinophils act as antigen-presenting cells to induce immunity to Strongyloides stercoralis in mice. J Infect Dis (2007) 1.25
Interferon-gamma and interleukin-4 responses in relation to serum IgE levels in persons infected with human T lymphotropic virus type I and Strongyloides stercoralis. J Infect Dis (1998) 1.17
Strongyloides stercoralis: protective immunity to third-stage larvae inBALB/cByJ mice. Exp Parasitol (1995) 1.17
The role of B cells in immunity against larval Strongyloides stercoralis in mice. Parasite Immunol (2002) 1.16
Cytokine profile and immunomodulation in asymptomatic human T-lymphotropic virus type 1-infected blood donors. J Acquir Immune Defic Syndr (2001) 1.15
Chronic Strongyloides stercoralis infection in former British Far East prisoners of war. QJM (2004) 1.11
IL-12 eliminates the Th-2 dependent protective immune response of mice to larval Strongyloides stercoralis. Parasite Immunol (1997) 1.11
Human T-cell lymphotropic virus type 1 p12I enhances interleukin-2 production during T-cell activation. J Virol (2003) 1.07
Foxp3 expression on normal and leukemic CD4+CD25+ T cells implicated in human T-cell leukemia virus type-1 is inconsistent with Treg cells. Eur J Haematol (2008) 1.05
Strongyloidiasis in patients at a comprehensive cancer center in the United States. Cancer (2004) 1.01
Specificity and mechanism of immunoglobulin M (IgM)- and IgG-dependent protective immunity to larval Strongyloides stercoralis in mice. Infect Immun (2003) 1.01
SYBR Green-based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: influence of clinical status, sex, and familial relatedness. J Neurovirol (2006) 1.00
Human immunoglobulin G mediates protective immunity and identifies protective antigens against larval Strongyloides stercoralis in mice. J Infect Dis (2004) 0.99
Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1. Clin Exp Immunol (2002) 0.94
The biology and genomics of Strongyloides. Med Microbiol Immunol (2006) 0.92
Attempts to establish infections with Strongyloides stercoralis in mice and other laboratory animals. J Helminthol (1982) 0.81
Strongyloides hyperinfection in patients coinfected with HTLV-I and S. stercoralis. Am J Med (1993) 0.80
Eosinophil-selective mediators in human strongyloidiasis. Parasite Immunol (2006) 0.80
[Thiabendazole for the control of Strongyloides stercoralis infection in a hyperendemic area in Peru]. Rev Gastroenterol Peru (2005) 0.79
Seroepidemiological aspects of human Strongyloides stercoralis infections in Chile. Rev Inst Med Trop Sao Paulo (2007) 0.78
Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med (2010) 32.89
Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis (2003) 15.02
Retention in care: a challenge to survival with HIV infection. Clin Infect Dis (2007) 10.66
Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS (2005) 5.08
Multidrug-resistant tuberculosis and culture conversion with bedaquiline. N Engl J Med (2014) 4.95
Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study. J Acquir Immune Defic Syndr (2007) 4.67
The business case for quality: case studies and an analysis. Health Aff (Millwood) (2003) 3.99
Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts. Cell Rep (2013) 3.85
Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis (2007) 3.80
Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia. Jt Comm J Qual Patient Saf (2005) 3.68
Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev (2002) 3.37
Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. Int J Epidemiol (2007) 3.22
An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med (2004) 3.12
Clustered local transmission and asymptomatic Plasmodium falciparum and Plasmodium vivax malaria infections in a recently emerged, hypoendemic Peruvian Amazon community. Malar J (2005) 2.77
Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin Infect Dis (2005) 2.75
Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation. Hepatology (2002) 2.71
Patients referred to an urban HIV clinic frequently fail to establish care: factors predicting failure. AIDS Care (2005) 2.64
Arboviral etiologies of acute febrile illnesses in Western South America, 2000-2007. PLoS Negl Trop Dis (2010) 2.60
The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis (2005) 2.43
Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic. J Acquir Immune Defic Syndr (2003) 2.33
Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the Caribbean. J Acquir Immune Defic Syndr (2009) 2.15
Neurocysticercosis: A natural human model of epileptogenesis. Epilepsia (2014) 2.11
New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). Am J Trop Med Hyg (2005) 2.10
Intact fetal cells in maternal plasma: are they really there? Lancet (2003) 2.09
Flow cytometric analysis of circulating microparticles in plasma. Cytometry A (2010) 2.09
Strongyloides hyperinfection syndrome: an emerging global infectious disease. Trans R Soc Trop Med Hyg (2008) 2.09
An updated review on Cryptosporidium and Giardia. Gastroenterol Clin North Am (2006) 2.05
Neuroendoscopic diagnosis of central nervous system histoplasmosis with basilar arachnoiditis. World Neurosurg (2011) 2.05
Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases. Antimicrob Agents Chemother (2002) 2.00
The laboratory diagnosis and follow up of strongyloidiasis: a systematic review. PLoS Negl Trop Dis (2013) 1.96
Neurocysticercosis: neglected but not forgotten. PLoS Negl Trop Dis (2012) 1.95
Cutaneous tuberculosis. Clin Dermatol (2007) 1.92
Determining risk for severe leptospirosis by molecular analysis of environmental surface waters for pathogenic Leptospira. PLoS Med (2006) 1.92
Using a framework for spread: The case of patient access in the Veterans Health Administration. Jt Comm J Qual Patient Saf (2005) 1.87
Human leptospirosis caused by a new, antigenically unique Leptospira associated with a Rattus species reservoir in the Peruvian Amazon. PLoS Negl Trop Dis (2008) 1.87
Sustained antiretroviral effect of raltegravir after 96 weeks of combination therapy in treatment-naive patients with HIV-1 infection. J Acquir Immune Defic Syndr (2009) 1.83
Discovery of Potent and Selective Inhibitors of Calcium-Dependent Protein Kinase 1 (CDPK1) from C. parvum and T. gondii. ACS Med Chem Lett (2010) 1.82
Rapid dissemination and diversity of CTX-M extended-spectrum beta-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America. Antimicrob Agents Chemother (2007) 1.81
Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 year follow-up study. AIDS (2004) 1.74
Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine. J Infect Dis (2005) 1.72
Prevention of sexually transmitted diseases (STDs) in female sex workers: prospective evaluation of condom promotion and strengthened STD services. Sex Transm Dis (2003) 1.70
Update on hepatobiliary flukes: fascioliasis, opisthorchiasis and clonorchiasis. Curr Opin Infect Dis (2008) 1.70
High prevalence of HIV and syphilis in a remote native community of the Peruvian Amazon. Am J Trop Med Hyg (2007) 1.70
Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM). AIDS Res Hum Retroviruses (2006) 1.67
Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. Cochrane Database Syst Rev (2016) 1.66
A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis. Am J Med (2002) 1.61
Strongyloides stercoralis: there but not seen. Curr Opin Infect Dis (2010) 1.60
Educational programs to enhance medical expertise in tropical diseases: the Gorgas Course experience 1996-2001. Am J Trop Med Hyg (2002) 1.60
Aqp2-expressing cells give rise to renal intercalated cells. J Am Soc Nephrol (2013) 1.59
Update on strongyloidiasis in the immunocompromised host. Curr Infect Dis Rep (2011) 1.59
A double-blind randomized controlled trial of antenatal mebendazole to reduce low birthweight in a hookworm-endemic area of Peru. Trop Med Int Health (2006) 1.55
Detrimental effects of adenosine signaling in sickle cell disease. Nat Med (2010) 1.54
Environmental temperature, cholera, and acute diarrhoea in adults in Lima, Peru. J Health Popul Nutr (2004) 1.54
Cross-sectional analysis of late HAART initiation in Latin America and the Caribbean: late testers and late presenters. PLoS One (2011) 1.53
Current status of carbapenemases in Latin America. Expert Rev Anti Infect Ther (2013) 1.52
Antigen-specific acquired immunity in human brucellosis: implications for diagnosis, prognosis, and vaccine development. Front Cell Infect Microbiol (2012) 1.52
A positive enzyme-linked immunoelectrotransfer blot assay result for a patient without evidence of cysticercosis. Clin Infect Dis (2002) 1.49
Synergistic effects of concurrent blockade of PI3K and MEK pathways in pancreatic cancer preclinical models. PLoS One (2013) 1.47
Asymptomatic renal colonization of humans in the peruvian Amazon by Leptospira. PLoS Negl Trop Dis (2010) 1.46
Evolution of methicillin-resistant Staphylococcus aureus clones in Latin America. Int J Infect Dis (2010) 1.45
Zoonoses and marginalised infectious diseases of poverty: where do we stand? Parasit Vectors (2011) 1.44
Use of ivermectin to treat an institutional outbreak of scabies in a low-resource setting. Infect Control Hosp Epidemiol (2007) 1.44
Cell-free fetal DNA in maternal blood: kinetics, source and structure. Hum Reprod Update (2004) 1.43
Can serum surfactant protein D or CC-chemokine ligand 18 predict outcome of interstitial lung disease in patients with early systemic sclerosis? J Rheumatol (2013) 1.43
Quantitative real-time polymerase chain reaction for enteropathogenic Escherichia coli: a tool for investigation of asymptomatic versus symptomatic infections. Clin Infect Dis (2011) 1.42
Contemporary neurosurgical approaches to neurocysticercosis. Am J Trop Med Hyg (2009) 1.41
How can clinicians measure safety and quality in acute care? Int J Nurs Stud (2011) 1.40
Histopathological features of tungiasis in Peru. Am J Trop Med Hyg (2013) 1.39
Detection of CTX-M-type beta-lactamase genes in fecal Escherichia coli isolates from healthy children in Bolivia and Peru. Antimicrob Agents Chemother (2004) 1.39
Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin America. PLoS One (2010) 1.37
Natural history, clinicoradiologic correlates, and response to triclabendazole in acute massive fascioliasis. Am J Trop Med Hyg (2008) 1.37
Relationship between intensity of soil-transmitted helminth infections and anemia during pregnancy. Am J Trop Med Hyg (2005) 1.36
Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease. Cochrane Database Syst Rev (2014) 1.35
Strongyloides stercoralis: a plea for action. PLoS Negl Trop Dis (2013) 1.33
Diversity of bat-associated Leptospira in the Peruvian Amazon inferred by bayesian phylogenetic analysis of 16S ribosomal DNA sequences. Am J Trop Med Hyg (2005) 1.33
Epidemiology of neurocysticercosis in Houston, Texas. Am J Trop Med Hyg (2005) 1.30
Severe Rift Valley fever may present with a characteristic clinical syndrome. Am J Trop Med Hyg (2010) 1.29
Treatment of cryptosporidiosis: do we know what we think we know? Curr Opin Infect Dis (2010) 1.29
Multidrug-resistant commensal Escherichia coli in children, Peru and Bolivia. Emerg Infect Dis (2006) 1.28
Zoonotic larval cestode infections: neglected, neglected tropical diseases? PLoS Negl Trop Dis (2009) 1.26
How can clinicians measure safety and quality in acute care? Lancet (2004) 1.25
Systems biology approach predicts antibody signature associated with Brucella melitensis infection in humans. J Proteome Res (2011) 1.24
A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis. J Infect Dis (2013) 1.23
Sequential outbreaks of infections by distinct Acinetobacter baumannii strains in a public teaching hospital in Houston, Texas. J Clin Microbiol (2007) 1.23
Evaluation of Fas2-ELISA for the serological detection of Fasciola hepatica infection in humans. Am J Trop Med Hyg (2007) 1.22
Neurocysticercosis in Houston, Texas: an update. Medicine (Baltimore) (2011) 1.19
HTLV in the Americas: challenges and perspectives. Rev Panam Salud Publica (2006) 1.19
Metabolic basis of HIV-lipodystrophy syndrome. Am J Physiol Endocrinol Metab (2002) 1.18
Human febrile illness caused by encephalomyocarditis virus infection, Peru. Emerg Infect Dis (2009) 1.18
Evidence of ongoing immune reconstitution in subjects with sustained viral suppression following 6 years of lopinavir-ritonavir treatment. Clin Infect Dis (2007) 1.17
Cost-effectiveness analysis of introduction of rapid, alternative methods to identify multidrug-resistant tuberculosis in middle-income countries. Clin Infect Dis (2008) 1.17
Isotope ratios of H, C, and O in CO2 and H2O of the martian atmosphere. Science (2013) 1.15